Literature DB >> 32756233

Insomnia.

Maria Nichole Perez, Rachel Marie E Salas.   

Abstract

PURPOSE OF REVIEW: This article provides updated information regarding the diagnosis and treatment of chronic insomnia disorder. In addition to discussing the latest recommendations regarding pharmacotherapeutic options for insomnia, this article also discusses the increased use of nonpharmacologic treatment approaches, including cognitive-behavioral therapy intervention, integrative medicine, mindfulness and meditation, and other therapeutic options in clinical practice. RECENT
FINDINGS: Insomnia is one of the most common sleep disorders in patients with other neurologic disorders. The definition and criteria for insomnia were updated with the release of the International Classification of Sleep Disorders, Third Edition. The American Academy of Sleep Medicine has updated clinical practice guidelines for the pharmacologic treatment of chronic insomnia in adults. New diagnostic and therapeutic options (eg, pharmacologic and behavioral therapies, at-home devices) have emerged to optimize and personalize the evaluation and management of sleep disorders such as insomnia. Although some of these devices and treatment options are still in the early stages of development, several are currently in clinical trials or will soon be available.
SUMMARY: This article emphasizes complexities related to the evaluation and management of patients with chronic insomnia disorder and describes alternative therapeutic options for patients with this common sleep disorder.

Entities:  

Mesh:

Year:  2020        PMID: 32756233     DOI: 10.1212/CON.0000000000000879

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  1 in total

1.  Proteomics Reveals Molecular Changes in Insomnia Patients with More Dreams.

Authors:  Tao Liu; Xingping Zhang; Guanying Wang; Xin Liu; Zhengting Liang; Xiaojuan Ren; Chen Chen; Deqi Yan; Wenhui Zhang
Journal:  Comput Math Methods Med       Date:  2022-04-08       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.